Skip to main content
main-content

Zeitschrift

Annals of Surgical Oncology

Annals of Surgical Oncology 2/2017

Ausgabe 2/2017

Inhaltsverzeichnis ( 42 Artikel )

14.10.2016 | Healthcare Policy and Outcomes | Ausgabe 2/2017

Disparities in Rectal Cancer: Moving from Descriptions to Solutions

Jason B. Liu MD, Clifford Y. Ko MD, MS, MSHS, FACS, FASCRS

12.09.2016 | Melanomas | Ausgabe 2/2017

Revisiting the Strait of Messina: The Balance Between Optimal Oncologic Outcomes and Complications From Surgery

Keith A. Delman MD, Michael C. Lowe MD

01.09.2016 | Gynecologic Oncology | Ausgabe 2/2017

Improving Surgical Site Infection Rates Through Continuous Quality Improvement

Jamie N. Bakkum-Gamez MD, Sean C. Dowdy MD

26.09.2016 | Urologic Oncology | Ausgabe 2/2017

Metastasectomy for Metastatic Renal Cell Carcinoma (mRCC): Lucky Break or Evidence-Based Approach?

Manuela Schmidinger MD

20.10.2016 | Healthcare Policy and Outcomes | Ausgabe 2/2017

Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II–III Rectal Cancer

David Y. Lee MD, Annabelle Teng MD, Rose C. Pedersen MD, Farees R. Tavangari MD, Vikram Attaluri MD, Elisabeth C. McLemore MD, Stacey L. Stern MS, Anton J. Bilchik MD, PhD, Melanie R. Goldfarb MD, MSc, FACS, FACE

09.09.2016 | Healthcare Policy and Outcomes | Ausgabe 2/2017

Impact of Location of Readmission on Outcomes After Major Cancer Surgery

Karyn B. Stitzenberg MD, MPH, YunKyung Chang PhD, MPH, Angela B. Smith MD, MS, Michael O. Meyers MD, Matthew E. Nielsen MD, MS

12.08.2016 | Melanomas | Ausgabe 2/2017 Open Access

Morbidity After Inguinal Lymph Node Dissections: It Is Time for a Change

Marloes Faut MD, Rianne M. Heidema MD, Harald J. Hoekstra MD, PhD, Robert J. van Ginkel MD, PhD, S. Lukas B. Been MD, PhD, Schelto Kruijff MD, PhD, Barbara L. van Leeuwen MD, PhD

05.08.2016 | Melanomas | Ausgabe 2/2017

Lymph Node Ratio Is Less Prognostic in Melanoma When Minimum Node Retrieval Thresholds Are Not Met

Mark A. Healy MD, MS, Evan Reynolds MS, Mousumi Banerjee PhD, Sandra L. Wong MD, MS

28.07.2016 | Melanomas | Ausgabe 2/2017

Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling

Nicholas Latchana MD, Sara E. Martin del Campo MD, Valerie P. Grignol MD, Jennifer R. Clark MD, Scott P. Albert MD, Jie Zhang PhD, Lai Wei PhD, Jennifer H. Aldrink MD, Kathleen K. Nicol MD, Mark A. Ranalli MD, Sara B. Peters MD, Alejandro Gru MD, Prashant Trihka PhD, Philip R. O. Payne PhD, J. Harrison Howard MD, William E. Carson III MD

22.09.2016 | Melanomas | Ausgabe 2/2017

Comparison of Single-Photon Emission Computed Tomography–Computed Tomography (SPECT/CT) and Conventional Planar Lymphoscintigraphy for Sentinel Node Localization in Patients with Cutaneous Malignancies

Matthew P. Doepker MD, Maki Yamamoto MD, Matthew A. Applebaum MS, Nupur U. Patel MS, M. Jaime Montilla-Soler MD, Amod A. Sarnaik MD, C. Wayne Cruse MD, Vernon K. Sondak MD, Jonathan S. Zager MD, FACS

29.08.2016 | Gynecologic Oncology | Ausgabe 2/2017

The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology

Jolyn S. Taylor MD, MPH, Claire A. Marten PharmD, Mark F. Munsell MS, Charlotte C. Sun DrPh, Kimberly A. Potts RN, Jennifer K. Burzawa MD, Alpa M. Nick MD, MS, Larissa A. Meyer MD, MPH, Keith Myers BS, Diane C. Bodurka MD, MPH, Thomas A. Aloia MD, Charles F. Levenback MD, David R. Lairson PhD, Kathleen M. Schmeler MD

23.09.2016 | Urologic Oncology | Ausgabe 2/2017

How Did We Obtain Complete Remission in Patients Who Had Metastatic Renal Cancer in the Era of Targeted Therapies?

François Brécheteau MD, Souhil Lebdai MD, Julie Carrouget MD, Jérôme Lebigot MD, Cosmina Nedelcu MD, Marie-Christine Rousselet MD, PhD, Nathalie Baize MD, Abdel Rhamène Azzouzi MD, PhD, Pierre Bigot MD, PhD

08.12.2016 | Breast Oncology | Ausgabe 2/2017

Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy

Kelly K. Hunt MD, David M. Euhus MD, Judy C. Boughey MD, Anees B. Chagpar MD, Sheldon M. Feldman MD, Nora M. Hansen MD, Swati A. Kulkarni MD, David R. McCready MD, Eleftherios P. Mamounas MD, Lee G. Wilke MD, Kimberly J. Van Zee MD, Monica Morrow MD

23.09.2016 | Breast Oncology | Ausgabe 2/2017

Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial

Irene L. Wapnir MD, Shari Gelber MS, Stewart J. Anderson PhD, Eleftherios P. Mamounas MD, André Robidoux MD, Miguel Martín MD, Johan W. R. Nortier MD, Charles E. Geyer Jr MD, Alexander H. G. Paterson MD, István Láng MD, Karen N. Price BS, Alan S. Coates MD, Richard D. Gelber PhD, Priya Rastogi MD, Meredith M. Regan ScD, Norman Wolmark MD, Stefan Aebi MD, On behalf of CALOR trial investigators

23.09.2016 | Breast Oncology | Ausgabe 2/2017

Loss of Anti-HER-3 CD4+ T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes

Megan Fracol MD, Jashodeep Datta MD, Lea Lowenfeld MD, Shuwen Xu MD, Paul J. Zhang MD, Carla S. Fisher MD, Brian J. Czerniecki MD, PhD

23.09.2016 | Breast Oncology | Ausgabe 2/2017

Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study

Akiko Chiba MD, Tanya L. Hoskin MS, Courtney N. Heins BS, Kelly K. Hunt MD, Elizabeth B. Habermann PhD, Judy C. Boughey MD

26.10.2016 | Bone and Soft Tissue Sarcomas | Ausgabe 2/2017

Implications of Lymph Node Evaluation in the Management of Resectable Soft Tissue Sarcoma

Brett L. Ecker MD, Madalyn G. Peters MD, Matthew T. McMillan BA, Andrew J. Sinnamon MD, Paul J. Zhang MD, Rachel R. Kelz MD, Robert E. Roses MD, Jeffrey A. Drebin MD, PhD, Douglas L. Fraker MD, Giorgos C. Karakousis MD

21.09.2016 | Bone and Soft Tissue Sarcomas | Ausgabe 2/2017

Prognosis of Fibrosarcoma in Patients With and Without a History of Radiation for Nasopharyngeal Carcinoma

Peng Zhang MD, Lei Zhao MD, Yu-Jia Zhu MD, Bo Qiu MD, Su-Ping Guo MS, Yong Li MD, Qing Liu MD, Meng-Zhong Liu MD, Mian Xi MD

05.08.2016 | Colorectal Cancer | Ausgabe 2/2017

Laparoscopic Anterior Resection with Transvaginal Specimen Extraction (TVSE) for Colorectal Cancer and Concomitant Total Hysterectomy and Bilateral Salpingo-Oophrectomy (THBSO): A Technical Description

Chun-Han Nigel Tan MBBS, MRCS (Edin), Choon-Seng Chong MBBS, M Med (Surgery), FRCSEd (Gen Surg), Yoke-Fai Fong MBBS, MRCOG (UK), M Med (O&G), FRANZCOG (Aust/NZ), FAMS, Shakina Rauff MBBS, MRCOG (UK), M Med (O&G), FAMS, Ker-Kan Tan MBBS, M Med (Surgery), FRCSEd (Gen Surg)

13.09.2016 | Endocrine Tumors | Ausgabe 2/2017

Computed Tomography-Detected Central Lymph Node Metastasis in Ultrasonography Node-Negative Papillary Thyroid Carcinoma: Is It Really Significant?

Seo Ki Kim MD, Jung-Woo Woo MD, Inhye Park MD, Jun Ho Lee MD, Jun-Ho Choe MD, PhD, Jung-Han Kim MD, PhD, Jee Soo Kim MD, PhD

23.09.2016 | Endocrine Tumors | Ausgabe 2/2017

Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Transarterial Chemoembolization using Streptozotocin: A 20-Year Experience

Mashaal Dhir MBBS, Ruchi Shrestha MD, Jennifer L. Steel PhD, J. Wallis Marsh MD, MBA, Allan Tsung MD, Mitchel E. Tublin MD, Nikhil B. Amesur MD, Philip D. Orons DO, Ernesto Santos MD, David A. Geller MD

21.09.2016 | Endocrine Tumors | Ausgabe 2/2017

Extent of Extrathyroidal Extension as a Significant Predictor of Nodal Metastasis and Extranodal Extension in Patients with Papillary Thyroid Carcinoma

Ji Won Kim MD, Jong-Lyel Roh MD, PhD, Gyungyup Gong MD, PhD, Kyung-Ja Cho MD, PhD, Seung-Ho Choi MD, PhD, Soon Yuhl Nam MD, PhD, Sang Yoon Kim MD, PhD

03.08.2016 | Gastrointestinal Oncology | Ausgabe 2/2017

Short- and Long-Term Outcomes After Gastrectomy in Elderly Gastric Cancer Patients

Jun-Young Yang MD, Hyuk-Joon Lee MD, PhD, Tae Han Kim MD, Yeon-Ju Huh MD, Young-Gil Son MD, PhD, Ji-Ho Park MD, Hye Seong Ahn MD, PhD, Yun-Suhk Suh MD, Seong-Ho Kong MD, PhD, Han-Kwang Yang MD, PhD

09.08.2016 | Gastrointestinal Oncology | Ausgabe 2/2017

Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Neoadjuvant Intraperitoneal/Systemic Chemotherapy on Peritoneal Metastases from Gastric Cancer

Yutaka Yonemura PhD, Haruaki Ishibashi MD, Masamitu Hirano PhD, Akiyoshi Mizumoto PhD, Kazuyosi Takeshita PhD, Kousuke Noguchi PhD, Nobuyuki Takao MD, Masumi Ichinose PhD, Yang Liu MD, Yan Li PhD

12.09.2016 | Gastrointestinal Oncology | Ausgabe 2/2017

Influence of Total Lymph Node Count on Staging and Survival After Gastrectomy for Gastric Cancer: An Analysis From a Two-Institution Database in China

Jun Lu MD, Wei Wang MD, Chao-hui Zheng MD, Cheng Fang MD, Ping Li MD, Jian-wei Xie MD, Jia-bin Wang MD, Jian-xian Lin MD, Qi-yue Chen MD, Long-long Cao MD, Mi Lin MD, Chang-ming Huang MD, PhD, Zhi-wei Zhou MD, PhD

09.09.2016 | Gastrointestinal Oncology | Ausgabe 2/2017

Ultrasonically Activated Shears Reduce Blood Loss without Increasing Inflammatory Reactions in Open Distal Gastrectomy for Cancer: A Randomized Controlled Study

Seung-Young Oh MD, Boram Choi MS, Kyung-Goo Lee MD, Hwi-Nyeong Choe BN, Hye-Joo Lee BN, Yun-Suhk Suh MD, Seong-Ho Kong MD, PhD, Hyuk-Joon Lee MD, PhD, Woo Ho Kim MD, PhD, Han-Kwang Yang MD, PhD

06.09.2016 | Gastrointestinal Oncology | Ausgabe 2/2017

Proposal of the Coagulation Score as a Predictor for Short-Term and Long-Term Outcomes of Patients with Resectable Gastric Cancer

Mitsuro Kanda MD, PhD, FACS, Chie Tanaka MD, PhD, Daisuke Kobayashi MD, PhD, Akira Mizuno MD, Yuri Tanaka MD, Hideki Takami MD, PhD, Naoki Iwata MD, PhD, Masamichi Hayashi MD, PhD, Yukiko Niwa MD, PhD, Suguru Yamada MD, PhD, FACS, Tsutomu Fujii MD, PhD, FACS, Hiroyuki Sugimoto MD, PhD, Kenta Murotani PhD, Michitaka Fujiwara MD, PhD, Yasuhiro Kodera MD, PhD, FACS

08.09.2016 | Gastrointestinal Oncology | Ausgabe 2/2017

Role of Prealbumin as a Powerful and Simple Index for Predicting Postoperative Complications After Gastric Cancer Surgery

J. Zhou MD, PhD, N. Hiki MD, PhD, S. Mine MD, PhD, K. Kumagai MD, PhD, S. Ida MD, PhD, X. Jiang MD, PhD, S. Nunobe MD, PhD, M. Ohashi MD, PhD, T. Sano MD, PhD, T. Yamaguchi MD, PhD

01.08.2016 | Hepatobiliary Tumors | Ausgabe 2/2017

Prognostic Significance of Tumor Necrosis in Hilar Cholangiocarcinoma

Georgi Atanasov MD, Katrin Schierle MD, Hans-Michael Hau MD, Corinna Dietel PhD, Felix Krenzien MD, Andreas Brandl MD, Georg Wiltberger MD, Julianna Paulina Englisch, Simon C. Robson MD, PhD, Anja Reutzel-Selke PhD, Andreas Pascher MD, PhD, Sven Jonas MD, PhD, Johann Pratschke MD, PhD, Christian Benzing MD, Moritz Schmelzle MD, PhD

16.08.2016 | Hepatobiliary Tumors | Ausgabe 2/2017 Open Access

The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer

Michał Grąt MD, PhD, Karolina M. Wronka MD, Jan Stypułkowski, Emil Bik, Maciej Krasnodębski MD, Łukasz Masior MD, Zbigniew Lewandowski PhD, Karolina Grąt MD, Waldemar Patkowski MD, PhD, Marek Krawczyk MD, PhD

29.08.2016 | Hepatobiliary Tumors | Ausgabe 2/2017

Predictive Profile-Nomogram for Liver Resection for Breast Cancer Metastases: An Aggressive Approach with Promising Results

Aldrick Ruiz MD, Dennis A. Wicherts MD, PhD, Mylène Sebagh MD, Sylvie Giacchetti MD, Carlos Castro-Benitez MD, Richard van Hillegersberg MD, PhD, Bernard Paule MD, Denis Castaing MD, Jean-François Morère MD, René Adam MD, PhD

08.09.2016 | Hepatobiliary Tumors | Ausgabe 2/2017

The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer

Masato Kataoka MD, Mitsuro Kanda MD, Kiyoshi Ishigure MD, Hiroshi Matsuoka MD, Yusuke Sato MD, Takao Takahashi MD, Chihiro Tanaka MD, Tomohiro Deguchi MD, Yoshihisa Shibata MD, Mikinori Sato MD, Hitoshi Inagaki MD, Takanori Matsui MD, Akinori Kondo MD, Nao Takano MD, Haruyoshi Tanaka MD, Junichi Sakamoto MD, Koji Oba MD, Ken Kondo MD

28.09.2016 | Hepatobiliary Tumors | Ausgabe 2/2017

Laparoscopic Right Hepatectomy: Toward Protocolization and Simplification

Sung Hoon Choi MD, Gi Hong Choi MD PhD, Dai Hoon Han MD, Sung Won Kwon MD PhD, Jin Sub Choi MD PhD

18.07.2016 | Hepatobiliary Tumors | Ausgabe 2/2017

Liver and Vena Cava En Bloc Resection for an Invasive Leiomyosarcoma Causing Budd–Chiari Syndrome, Under Veno-Venous Bypass and Liver Hypothermic Perfusion

Liver Hypothermic Perfusion and Veno-Venous Bypass for Inferior Vena Cava Leiomyosarcoma
Matteo Ravaioli MD, PhD, Matteo Serenari MD, Matteo Cescon MD, PhD, Carlo Savini MD, Alessandro Cucchetti MD, Giorgio Ercolani MD, PhD, Massimo Del Gaudio MD, PhD, Alberto Casati MD, Antonio Daniele Pinna MD, PhD

06.06.2016 | Original Article – Hepatobiliary Tumors | Ausgabe 2/2017

Laparoscopic Right Hepatectomy for Cirrhotic Patients: Takasaki’s Hilar Control and Caudal Approach

Jaime Arthur Pirola Krüger MD, Gilton Marques Fonseca MD, Fabrício Ferreira Coelho MD, PhD, Vagner Jeismann MD, Paulo Herman MD, PhD

02.09.2016 | Pancreatic Tumors | Ausgabe 2/2017

Laparoscopic Spleen-Preserving Total Pancreatectomy for a Main-Duct Intraductal Papillary Mucinous Neoplasm

Brandon C. Chapman MD, Alessandro Paniccia MD, Carrie Ryan MS, Richard D. Schulick MD, Barish H. Edil MD

20.09.2016 | Pancreatic Tumors | Ausgabe 2/2017

Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer

Zuqiang Liu MD, Kaizhou Jin MD, Meng Guo PhD, Jiang Long MD, Liang Liu MD, Chen Liu MD, Jin Xu MD, Quanxing Ni MD, Guopei Luo MD, PhD, Xianjun Yu MD, PhD

29.08.2016 | Thoracic Oncology | Ausgabe 2/2017

Proximal Resection Margin in Ivor-Lewis Oesophagectomy for Cancer

Y. A. Qureshi MBBS, MRCS, MSc, FRCS, S.-J. Sarker MSc(Stat), MSc(Epid), PhD, PGCAP, R. C. Walker MBChB, MRCS, S. F. Hughes MS, FRCS

15.12.2015 | Translational Research and Biomarkers | Ausgabe 2/2017

Methylation of the Tumor Suppressor Genes HIC1 and RassF1A Clusters Independently From the Methylation of Polycomb Target Genes in Colon Cancer

Hong-Chang Chen MD, Hsuan-Yuan Huang MD, Yao-Li Chen MD, Kuan-Der Lee MD, PhD, Yi-Ru Chu MS, Ping-Yi Lin PhD, Chia-Chen Hsu PhD, Pei-Yi Chu MD, PhD, Tim H.-M. Huang PhD, Shu-Huei Hsiao PhD, Yu-Wei Leu PhD

16.12.2015 | Translational Research and Biomarkers | Ausgabe 2/2017

As a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma

Ryosuke Desaki MD, Genta Sawada MD, Hiroshi Okumura MD, Ryuji Ikeda PhD, Kan Tanabe MD, Hisateru Komatsu MD, Koshi Mimori MD, PhD, Masaki Mori MD, PhD, FACS, Yoshiaki Kita MD, PhD, Yasuto Uchikado MD, PhD, Takaaki Arigami MD, PhD, Yoshikazu Uenosono MD, PhD, Tetsuhiro Owaki MD, PhD, Sumiya Ishigami MD, PhD, Shoji Natsugoe MD, PhD

01.02.2016 | Translational Research and Biomarkers | Ausgabe 2/2017

Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer

Shoichiro Mukai MD, Naohide Oue MD, PhD, Takashi Oshima MD, PhD, Risa Mukai MD, Yoshiko Tatsumoto PhD, Naoya Sakamoto MD, PhD, Kazuhiro Sentani MD, PhD, Kazuaki Tanabe MD, PhD, Hiroyuki Egi MD, PhD, Takao Hinoi MD, PhD, Hideki Ohdan MD, PhD, Wataru Yasui MD, PhD

14.03.2016 | Translational Research and Biomarkers | Ausgabe 2/2017

MSH2 rs2303425 Polymorphism is Associated with Early-Onset Breast Cancer in Taiwan

Yi-Chen Hsieh PhD, Er-Chieh Cho PhD, Shih-Hsin Tu MD, Chih-Hsiung Wu MD, PhD, Chin-Sheng Hung MD, PhD, Mao-Chih Hsieh MD, PhD, Chien-Tien Su MD, MPH, PhD, Yun-Ru Liu PhD, Chia-Hwa Lee PhD, Yuan-Soon Ho PhD, Hung-Yi Chiou PhD

Aktuelle Ausgaben

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise